Supplemental material
Journal of Medical Economics
Volume 27, 2024 - Issue 1
Open access
628
Views
0
CrossRef citations to date
0
Altmetric
Migraine
Cost-effectiveness of rimegepant oral lyophilisate compared to best supportive care for the acute treatment of migraine in the UK
Karissa Johnstona Broadstreet Health Economics and Outcomes Research, Vancouver, CanadaCorrespondence[email protected]
https://orcid.org/0000-0003-4570-9972
, https://orcid.org/0000-0003-4570-9972
Lauren C. Powella Broadstreet Health Economics and Outcomes Research, Vancouver, Canadahttps://orcid.org/0000-0002-4329-5166
, Evan Popoffa Broadstreet Health Economics and Outcomes Research, Vancouver, Canadahttps://orcid.org/0000-0002-3233-3147
, Gil J. L’Italienb Biohaven Pharmaceuticals, New Haven, CT, USA
, Robert Pawinskic Pfizer Ltd, Tadworth, UKhttps://orcid.org/0009-0009-0769-6219
, Aideen Ahernc Pfizer Ltd, Tadworth, UKhttps://orcid.org/0000-0002-8912-6237
, Sam Largec Pfizer Ltd, Tadworth, UKhttps://orcid.org/0009-0008-9628-1922
, Thang Trand Pfizer Canada, Kirkland, Canadahttps://orcid.org/0009-0006-7007-3661
& Aaron Jenkinsc Pfizer Ltd, Tadworth, UKhttps://orcid.org/0000-0001-9785-9388
show all
Pages 627-643
|
Received 21 Dec 2023, Accepted 05 Apr 2024, Published online: 27 Apr 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.